These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24131479)

  • 1. Validation of the bladder control self-assessment questionnaire (B-SAQ) in men.
    Sahai A; Dowson C; Cortes E; Seth J; Watkins J; Khan MS; Dasgupta P; Cardozo L; Chapple C; De Ridder D; Wagg A; Kelleher C
    BJU Int; 2014 May; 113(5):783-8. PubMed ID: 24131479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ).
    Basra R; Artibani W; Cardozo L; Castro-Diaz D; Chapple C; Cortes E; De Ridder D; Pons ME; Haab F; Hohenfellner M; Kirby M; Milsom I; Van Kerrebroeck P; Vierhout M; Wagg A; Kelleher C
    Eur Urol; 2007 Jul; 52(1):230-7. PubMed ID: 17129667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison study of two lower urinary tract symptoms screening tools in clinical practice: the B-SAQ and OAB-V8 questionnaires.
    Basra RK; Cortes E; Khullar V; Kelleher C
    J Obstet Gynaecol; 2012 Oct; 32(7):666-71. PubMed ID: 22943714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing and validating the International Consultation on Incontinence Questionnaire bladder diary.
    Bright E; Cotterill N; Drake M; Abrams P
    Eur Urol; 2014 Aug; 66(2):294-300. PubMed ID: 24647230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.
    Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P
    Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.
    Chapple CR; Drake MJ; Van Kerrebroeck P; Cardozo L; Drogendijk T; Klaver M; Van Charldorp K; Hakimi Z; Compion G
    BJU Int; 2014 May; 113(5):696-703. PubMed ID: 24712917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women.
    Jimenez-Cidre MA; Lopez-Fando L; Esteban-Fuertes M; Prieto-Chaparro L; Llorens-Martinez FJ; Salinas-Casado J; Castro-Diaz D; Müller-Arteaga C; Adot-Zurbano JM; Rodriguez-Escobar F; Gutierrez C; Arlandis-Guzman S; Bonillo-Garcia MA; Madurga-Patuel B; Leva-Vallejo M; Franco de Castro A; Peri-Cusi L; Conejero-Sugrañes J; Jimenez-Calvo J; Rebollo P; Mora A
    Neurourol Urodyn; 2015 Feb; 34(2):128-32. PubMed ID: 24264859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom severity and patient perceptions in overactive bladder: how are they related?
    Homma Y; Gotoh M
    BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of the Spanish version of the "Bladder control Self-Assessment Questionnarie" (B-SAQ). A new screening instrument for lower urinary tract dysfunction].
    Espuña Pons M; Puig Clota M; Rebollo Alvarez P
    Actas Urol Esp; 2006; 30(10):1017-24. PubMed ID: 17253070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the King's Health Questionnaire for lower urinary tract symptoms in both genders.
    Okamura K; Nojiri Y; Osuga Y
    BJU Int; 2009 Jun; 103(12):1673-8. PubMed ID: 19154505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
    Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
    Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study.
    Fujimura T; Kume H; Tsurumaki Y; Yoshimura Y; Hosoda C; Suzuki M; Fukuhara H; Enomoto Y; Nishimatsu H; Homma Y
    Int J Urol; 2011 Nov; 18(11):778-84. PubMed ID: 21951201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.